US speeds up research into mind-altering drugs — including mysterious ‘ibogaine’
Nature April 21, 2026 Peer reviewed DOI: 10.1038/d41586-026-01286-1 via OpenAlex
Abstract
No abstract available from the source.
Related reading
- Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidence Psychedelics. • October 28, 2025 • via OpenAlex
- Quality of reporting on psychological interventions in psychedelic treatments: a systematic review The Lancet Psychiatry • December 9, 2024 • via OpenAlex
- From Underground to Mainstream: Establishing a Medical Lexicon for Psychedelic Therapy Frontiers in Psychiatry • June 17, 2022 • via OpenAlex
- Trump orders ibogaine and other psychedelics on fast track at FDA Alcoholism & Drug Abuse Weekly • April 24, 2026 • via OpenAlex
- Clinical psychedelic research in adolescents: a scoping review and overview of ethical considerations The Lancet Child & Adolescent Health • September 2, 2025 • via OpenAlex